Rando Hannah, Musoni Maurice, Greenwood Bonnie C, Ingabire Lambert, Van Hook Sam, Bolman Ceeya Patton, Bolman R Morton, Lin Yihan
Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Team Heart, Inc, Milton, MA, USA.
J Cardiothorac Surg. 2024 Oct 1;19(1):574. doi: 10.1186/s13019-024-03087-x.
Until local healthcare infrastructure is strengthened, cardiac surgical care in low- and middle-income countries is often provided by non-governmental organizations by way of visiting healthcare teams. This is generally considered to be a cost-effective alternative to transporting patients to high income countries for surgical care, but the costs of cardiac surgery consumables under this model are poorly understood. Our objective was to identify the per-patient cost of cardiac surgery consumables used in single and double valve replacements performed by a non-governmental organization in Rwanda.
Financial data from 2020 were collected from Team Heart, a non-governmental organization that supports cardiac surgical care in Rwanda. A comprehensive list of consumables was generated, including surgical, perfusion, anesthesia, and inpatient supplies and medications. Acknowledging the variability in perioperative needs, the quantities of consumables were calculated from an average of six patients who underwent single or double-valve replacement in 2020. Total costs were calculated by multiplying purchasing price by average quantity per patient. Costs absorbed by the local hospital were excluded from the calculations.
The total cost per patient was estimated at $9,450. Surgical supplies comprised the majority of costs ($6,140 per patient), with the most substantial cost being that of replacement valves ($3,500 per valve), followed by surgical supplies ($1,590 per patient).
This preliminary analysis identifies a cost of just over $9,000 per patient for consumables used in cardiac valve surgery in Rwanda, which is lower than the estimated costs of transporting patients to centers in high income countries. This work highlights the relative cost effectiveness of cardiac surgical care in low- and middle- income countries under this model and will be instrumental in guiding the allocation of local and international resources in the future.
在当地医疗基础设施得到加强之前,低收入和中等收入国家的心脏外科护理通常由非政府组织通过派遣医疗团队来提供。一般认为,这是一种比将患者转运到高收入国家进行外科护理更具成本效益的替代方案,但这种模式下心脏手术耗材的成本却鲜为人知。我们的目标是确定卢旺达一个非政府组织进行单瓣膜和双瓣膜置换手术时使用的心脏手术耗材的人均成本。
收集了2020年来自“心脏团队”(一个支持卢旺达心脏外科护理的非政府组织)的财务数据。生成了一份全面的耗材清单,包括手术、灌注、麻醉以及住院用品和药物。考虑到围手术期需求存在差异,耗材数量是根据2020年接受单瓣膜或双瓣膜置换手术的六名患者的平均用量计算得出的。总成本通过采购价格乘以人均平均用量来计算。计算中排除了当地医院承担的成本。
估计人均总成本为9450美元。手术用品占成本的大部分(人均6140美元),其中成本最高的是置换瓣膜(每个瓣膜3500美元),其次是手术用品(人均1590美元)。
这项初步分析确定卢旺达心脏瓣膜手术中使用的耗材人均成本略高于9000美元,这低于将患者转运到高收入国家中心的估计成本。这项工作凸显了这种模式下低收入和中等收入国家心脏外科护理的相对成本效益,并将有助于指导未来当地和国际资源的分配。